BofA Securities initiates Payoneer stock at Buy on B2B growth By Investing.com

BofA initiated coverage of Payoneer (PAYO) with a Buy and $6.00 price target, implying ~27% upside from $4.73 and near InvestingPro Fair Value of $6.34. Payoneer missed Q4 2025 estimates with EPS $0.05 vs $0.06 and revenue $261.7M vs $282.72M, though core revenue grew 9% YoY and B2B volumes rose 21%. BofA projects 2026–2028 CAGRs of 13% core revenue, 14% core adj. EBITDA and 15% free cash flow, citing a $6T B2B TAM and a 13% trailing free cash flow yield. Benchmark and Needham trimmed price targets (Benchmark $10→$7; Needham $10→$8) but kept Buy ratings, reflecting mixed near-term results amid constructive medium-term outlook.

Analysis

Payoneer sits at the intersection of three monetization vectors—FX spreads, accounts-payable/cards take-rates, and interest on client float—and the market is oscillating between pricing in secular scale versus cyclical funding pressure. The important second-order lever is regional mix: emerging-market corridors carry higher take-rates but also more volatile FX flows and credit risk, so a shift in volume composition toward enterprise marketplace customers can materially compress blended take-rate even as revenue nominally grows.

On competitiveness, Payoneer’s pathway to re-rating is structural rather than purely cyclical: productizing AP/payables, embedding card rails, and cross-selling FX hedging could lift gross yield per customer by high-single digits over 12–24 months if execution sticks. That outcome competes directly with modern acquirers and treasury providers (Stripe/Adyen/large FIs), meaning any pricing power realized will be contested and likely require either superior developer integrations or exclusive marketplace arrangements to be durable.

Key risks are idiosyncratic concentration (large marketplace relationships), macro-driven compression of interest income if global rates normalise downward, and regulatory friction in key corridors that can flip take-rates quickly. Near-term catalysts to watch are take-rate disclosures, a concrete buyback/dividend framework, and any Claude/AI-enabled product releases that demonstrably lower servicing costs — each could re-rate consensus multiples within 3–12 months if matched by unit-economics evidence.

Key Decisions for Investors

• Long PAYO equity (0.25% NAV starter, scale to 0.75% on positive take-rate commentary) — horizon 9–12 months. R/R: asymmetric — if management proves sustained take-rate lift and announces a capital return plan expect 30–60% upside; downside c. -40% if volumes fall or interest income compresses materially.
• Buy-timespread: PAYO 12–18 month call spread (buy LEAP call / sell higher strike) sized to limit premium to <0.5% NAV — horizon 12–24 months. This captures re-rating from product-led margin expansion while capping downside to the premium paid; target 2:1 upside-to-cost if take-rate and cash-return catalysts hit.
• Pair trade: Long PAYO / Short PYPL (equal notional) — horizon 6–12 months. Rationale: relative exposure to B2B FX/take-rate upside in PAYO vs broader consumer/payment exposure in PYPL; target relative outperformance of 15–25%, stop-loss if PAYO underperforms by 20% vs PYPL.
• Event-driven hedge: Buy short-dated put spread on PAYO ahead of the next quarterly release (protecting 3–5% downside in NAV sizing) — horizon days-to-weeks. This protects against an earnings-guidance miss or a negative surprise on interest/FX income while keeping capital at work for the structural recovery thesis.